EUCTR2011-002823-16-IT进行中（未招募）不适用
Effects of Vitamin D in patients affected by heart failure
A.O. UNIVERSITARIA INTEGRATA DI VERONA0 个研究点目标入组 36 人开始时间: 2012年3月7日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Written informed consent signed by the patient or by a legally acceptable representative; -Men and women between the ages of 40 and 85 years; -Patients affected by chronic heart failure (Framingham criteria), not in the acute phase, in NYHA class I-II-III-IV secondary to a hypertensive ischemic heart disease or an idiopathic dilated cardiomyopathy, and with echocardiographic assessment of both systolic heart failure (left ventricular ejection fraction = 50%) and heart failure with preserved systolic function (ejection fraction equal or > 45%, evidence of abnormal left ventricular relaxation); -Nutritional deficiency of Vitamin D (VIT D < 30 ng/mL and > 10 ng/mL).
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 36
排除标准
- •-unstable angina; -recent myocardial infarction (within the 6 months prior to enrollment) -cardiogenic shock or hypotension (systolic pressure <100 mm Hg) -uncontrolled hypertension (SBP> 180, DBP> 110); -severe liver disease -severe renal impairment (creatinine> 2mg/dl); -infectious or chronic inflammatory disease; -active cancer or haematological disease; -recent blood transfusion (within 30 days); -abuse of alcohol or drugs in the last year; -severe osteoporosis requiring treatment with bisphosphonates and / or vitamin D; -intake of vitamin D within the 3 months prior to enrollment.
研究者
相似试验
已完成
3 期
Effect of Vitamin D Supplementation on Cardiovascular and Respiratory Disease Event Rates, and the incidence of fracturesRespiratory DiseaseNon-vertebral fracturesCardiovascular - Coronary heart diseaseRespiratory - Chronic obstructive pulmonary diseaseInjuries and Accidents - FracturesCancer - Any cancerCancerCardiovascular DiseaseACTRN12611000402943niversity of Auckland5,110
进行中（未招募）
不适用
The effect of vitamin D supplementation on cardiovascular risk factors in subjects with low serum 25-hydroxyvitamin D levelssubjects with serum 25-hydroxyvitamin D < 35 nmol/L will be included and the effect of vitamin D supplementation versus placebo tested regarding cardiovascular risk factorsEUCTR2013-003514-40-NOniversity Hospital of North Norway
尚未招募
不适用
Effects of Vitamin D on the cardiovascular autonomic functions of subjects who are working in High Altitude Areas, in excess of 15000ft, for 3 to 4 months. This study will shed light on the Autonomic Nervous System, a specialized system of nerves that has profound effects on Heart.CTRI/2022/07/044289DGAFMS
已完成
4 期
Impact of vitamin D status on risk of cardiovascular disease.ACTRN12609000584235Department of Health100
进行中（未招募）
不适用
Vitamin D therapy to reduce cardiovascular risk in Type 2 diabetes – the next stepsEUCTR2007-003767-51-GBResearch and Innovation Services, University of Dundee